-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
There are limited data on the prevalence of clinical and neuroimaging findings in patients with cerebral amyloid angiopathy (CAA)
Blood vessel
We conducted a systematic review and meta-analysis of studies including patients with CAA, mainly including studies available to assess clinical phenotype and prevalence of neuroimaging markers
Research Design Statistics
The researchers identified 12 prospective studies and 34 retrospective studies enrolling 7159 patients with CAA
The only neuroimaging marker associated with a higher rate of ICH recurrence was superficial cortical siderosis (odds ratio, 1.
CONCLUSIONS : Cerebral microbleeds, superficial cortical siderosis, mild cognitive impairment, dementia, ICH, or transient focal neurologic seizures were observed in approximately half of the CAA patient cohort
Cerebral microbleeds, superficial cortical siderosis, mild cognitive impairment, dementia, ICH, or transient focal neurologic seizures were observed in approximately half of the CAA patient cohort
Original source:
Konark Malhotra.